Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- SIGNATUREIndependent statistical analysis of LDE225 for Patients With PTCH1 or SMO Mutated Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002689).
- Sildenafil Exercise: Role of PDE5 Inhibition: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil Exercise: Role of PDE5 Inhibition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04039087).
- Sildenafil for Chronic Obstructive Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil for Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00104637).
- Sildenafil for the Treatment of Lymphatic Malformations: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil for the Treatment of Lymphatic Malformations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02335242).
- Sildenafil Treatment for Mild TBI: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil Treatment for Mild TBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03598140).
- Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SILDI-SAFEIndependent statistical analysis of Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04447989).
- Silk’n HST Device Usability and Self Selection Study: Complete Statistical AnalysisIndependent statistical analysis of Silk'n HST Device Usability and Self Selection Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919007).
- Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04191421).
- Silver Diamine Fluoride and Papain-Based Gel for Management of MIH-affected Molar in Paediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Silver Diamine Fluoride and Papain-Based Gel for Management of MIH-affected Molar in Paediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section: Complete Statistical AnalysisIndependent statistical analysis of Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SIMAPIndependent statistical analysis of Pictograms to Facilitate Comprehension of Medical Indications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05609760).
- Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia: Complete Statistical AnalysisIndependent statistical analysis of Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia: primary endpoint results, effect estimate with confidence interval, sample-size…
- Simplified Insulin Regimen for the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Simplified Insulin Regimen for the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03660553).
- Simplified Negative Pressure Wound Therapy: Complete Statistical AnalysisIndependent statistical analysis of Simplified Negative Pressure Wound Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01339429).
- Simplifying Treatment and Monitoring for HIV (STREAM HIV): Complete Statistical AnalysisIndependent statistical analysis of Simplifying Treatment and Monitoring for HIV (STREAM HIV): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04341779).
- Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica: Complete Statistical AnalysisIndependent statistical analysis of Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Simulation Training for Labor and Delivery Providers to Address HIV Stigma During Childbirth in Tanzania: Complete Statistical AnalysisIndependent statistical analysis of Simulation Training for Labor and Delivery Providers to Address HIV Stigma During Childbirth in Tanzania: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Simultaneous Assessment of FFR and SPECT: Complete Statistical AnalysisIndependent statistical analysis of Simultaneous Assessment of FFR and SPECT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02749045).
- Simultaneous mRNA COVID-19 and IIV4 Vaccination Study: Complete Statistical AnalysisIndependent statistical analysis of Simultaneous mRNA COVID-19 and IIV4 Vaccination Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05028361).
- Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00919035).
- Single Ascending Dose Study of AMG 570 in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Single Ascending Dose Study of AMG 570 in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02618967).
- Single Dose CHG Pharmacokinetic Study: Complete Statistical AnalysisIndependent statistical analysis of Single Dose CHG Pharmacokinetic Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03331263).
- Single Dose Intranasal Oxytocin and Cognitive Effects in Autism: Complete Statistical AnalysisIndependent statistical analysis of Single Dose Intranasal Oxytocin and Cognitive Effects in Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02493426).
- Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611): Complete Statistical AnalysisIndependent statistical analysis of Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults: Complete Statistical AnalysisIndependent statistical analysis of Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old…
- Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Complete Statistical AnalysisIndependent statistical analysis of Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: primary endpoint results, effect estimate with confidence interval, sample-size…
- Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027): Complete Statistical AnalysisIndependent statistical analysis of Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01106287).
- Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Single Hormone Closed Loop Study With PDT Sensor: Complete Statistical AnalysisIndependent statistical analysis of Single Hormone Closed Loop Study With PDT Sensor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03528174).
- Single or Double-layer Uterine Closure Techniques: Complete Statistical AnalysisIndependent statistical analysis of Single or Double-layer Uterine Closure Techniques: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03629028).
- Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827: Complete Statistical AnalysisIndependent statistical analysis of Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Single-Sided Deafness in the Medicare Population: Complete Statistical AnalysisIndependent statistical analysis of Single-Sided Deafness in the Medicare Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05250414).
- Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SINUS-52Independent statistical analysis of Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02898454).
- SIPIIndependent statistical analysis of Satisfaction of Limited English-Proficient Patients With Phone Interpretation Services Compared to In-Person Interpreters: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- sipITIndependent statistical analysis of Feasibility of Using sipIT Tools to Increase Compliance With Fluid Consumption Guidelines in Urolithiasis-Prone Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SirolimusIndependent statistical analysis of Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sirolimus for Autoimmune Disease of Blood Cells: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus for Autoimmune Disease of Blood Cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00392951).
- Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02357342).
- SISCAIndependent statistical analysis of Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SISTA-PIndependent statistical analysis of Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06307028).
- SISTErIndependent statistical analysis of Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00064662).
- SISTERSIndependent statistical analysis of SISTERS: Spasticity In Stroke Study - Randomized Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01032239).
- Sitagliptin Added-on to Insulin Study (0431-051): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Added-on to Insulin Study (0431-051): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00395343).